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Structure and Function of the Stratum
Corneum Extracellular Matrix
Peter M. Elias1
The stratum corneum (SC) extracellular matrix (ECM) is enriched in lipids that are
organized into lamellar bilayers, whose molecular architecture is now known.
Although these bilayers are important for the permeability barrier, the ECM
contains not only lipids but also enzymes, structural proteins, and antimicrobial
peptides that impact barrier function. Yet, how such diverse components affect
barrier function remains largely unknown. Static models of the epidermis may not
do justice to the ECM, which is metabolically active, as it changes both structure
and function as it transits to the surface.
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A brief history of our understanding of
the stratum corneum interstices
Current understanding of the structure of
stratum corneum (SC) began with the
realization that its ‘‘normal basket-
weave structure’’ in histologic sections
is remarkably resilient, sharing charac-
teristics with plastic wrap. Yet, the
plastic wrap analogy is inaccurate; SC
is not a homogenous sheet; rather, it is a
geometrically arrayed, cellular tissue,
with corneocytes arranged in vertical,
interlocking columns (Christophers and
Kligman, 1964). Frozen sections of SC,
stained with lipid-detecting dyes, have
shown that lipids in SC are segregated to
membrane domains, a feature unique to
the epidermis and other keratinizing
epithelia, where they further localize
to the extracellular matrix (ECM) of the
SC, as shown by freeze-fracture repli-
cation and cell fractionation, which
further demonstrates the organization of
these lipids into lamellar bilayers (Elias
et al., 1977). These multilayers form
an expanded (E10% of SC volume)
domain that encloses corneocytes in a
continuum of broad lamellar membranes
(Elias and Friend, 1975).
Lamellar bilayer structure and function
Despite a lack of phospholipids,
the approximately 1:1:1 molar ratio of
ceramides (Cer), cholesterol, and non-
essential fatty acids allows the incor-
poration of these lipids into unique
multilamellar structures, with a charac-
teristic substructure (e.g., White et al.
(1988) and Bouwstra et al. (1991)).
Several models have been proposed to
illuminate how Cer, including certain
Cer species that are further o-esterified
by linoleic acid (acylCer), are deployed
within the lamellar bilayers. Although
these models generally show cholesterol
and free fatty acids lying alongside the
N-acyl group of Cer, Iwai et al. (this
issue, 2012) now propose that
cholesterol, instead, partners with the
sphingoid base of Cer and acylCer, with
the N-acyl group then forming outward-
extending arms.
As all three lipids are required to form
the lamellar structures that regulate bar-
rier function (Man et al., 1993), this new
model could be validated by ascertain-
ing whether pharmacologic blockade of
cholesterol synthesis (Feingold et al.,
1990) alters the predicted molecular
organization within the lamellar
bilayers. Similarly, blockade of either
fatty acid and/or Cer synthesis could
be used to further determine where
each lipid moiety is deployed within
the lamellar bilayers. Experiments of
Nature, in the form of ichthyosis in
See related article on pg 2215 inherited disorders of distal cholesterol
metabolism (Elias et al., 2011), have
been reported, in which cholesterol-
deficient scales could be examined to
address this issue. If this new model
withstands such experimental verifi-
cation, it would then prove useful in
assessing how the lamellar bilayers
contribute to the permeability barrier,
while also predicting the subcellular
routes by which hydrophobic and
amphiphilic molecules might preferen-
tially traverse the SC via the ECM.
The ECM contains more than lipids
The title of the paper by Iwai et al.
(2012) is somewhat misleading, because
SC membrane domains are hetero-
geneous (Figure 1), containing not only
lamellar bilayers but also the following:
(1) corneocyte envelopes; (2) the o-
hydroxyceramide monolayer that sur-
rounds corneocytes (i.e., the corneocyte
lipid envelope); and (3) several other
secreted enzymatic and structural pro-
teins generated from lamellar bodies.
These include the cathelicidin anti-
microbial peptide, LL-37, human
b-defensin 2, and corneodesmosin, as
well as several proteolytic enzymes and
their respective inhibitors. Many of these
constituents have been shown to con-
tribute to permeability barrier function.
For example, lamellar bilayers are dis-
organized in inherited disorders that
modify the corneocyte envelope, such
as transglutaminase 1–deficient lamellar
ichthyosis and loricrin keratoderma
(reviewed in Elias et al., 2010). Simi-
larly, lamellar bilayer organization is
altered when the corneocyte lipid
envelope is lost, as in ALOX-deficient
autosomal recessive ichthyosis, neutral
lipid storage disease (Chanarin–
Dorfman syndrome), and Refsum
disease (Elias et al., 2010). Finally,
transgenic ablation of the mouse
cathelicidin protein results in a barrier
abnormality owing to defective lamellar
bilayer organization.
The larger question then becomes:
how do all of these constituents partici-
pate in creating an effective, paracellu-
lar barrier to outward movement of
water while preventing the ingress of
noxious substances? Biophysical studies
on the molecular architecture of the
lamellar bilayers, although certainly
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important, have not yet taken into
consideration the composite structural
basis of the permeability barrier. Iwai
et al. (2012) leave other questions
unanswered: for example, they exami-
ned cryosections from an unspecified
depth (mid-SC). Specifically, how does
lamellar membrane architecture differ at
varying levels of SC? These bilayers
likely change in structure in response
to the dynamic requirements of a highly
cohesive structure that optimizes barrier
function in the lower SC, which then
relinquishes that role at more apical
sites in preparation for shedding.
Hence, information about the structure
of lamellar bilayers deep in the mid-SC
may not apply to bilayers at either more
proximal or distal levels.
Where is the water?
There is also the issue of hydration; i.e.,
the site(s) at which water is sequestered
in the SC. This much-debated subject is
not trivial, as the SC’s ability to imbibe
water allows humans to take baths and
to swim in fresh water without drown-
ing. Iwai et al. (2012) suggest that the
lamellar bilayer architecture is not
influenced by hydration, but the
evidence for this claim is incomplete—
a SC sample was immersed in water for
2 hours, after which no changes in
membrane architecture appeared to take
place. Yet, if the initial sample were
already fully hydrated, one might antici-
pate no further change. To resolve this
issue, future studies should include sam-
ples that are dried initially and then
rehydrated. Similarly, the evidence that
corneocytes alone imbibe water is
based upon visual observations of the
corneocyte interior alone. It should be
noted that several (potentially water-
binding) extracellular proteins are pre-
sent in the ECM. Some are secreted by
lamellar bodies, but others are derived
from the degradation of corneodesmo-
somes. As corneodesmosomes are
degraded, lacunae form, which then
appear to provide an aqueous pore
pathway through which hydrophilic
molecules might traverse the ECM
(Menon and Elias, 1997). In a report
not yet available to the investigators (Lin
et al., 2012), we have shown that these
lacunar domains expand with hydration,
as do the hydrophilic leaflets within
the lamellar bilayers. Furthermore, the
lamellar bilayers are degraded in the
mid- to outer-SC following hydration,
apparently through the activation of
acidic ceramidases. It appeared that
throughout these maneuvers only the
extracellular compartment changed in
volume with hydration. Thus, it would
appear that the extracellular, rather than
the cellular, compartment in the mid- to
outer-SC expands and contracts in
response to changes in hydration.
Limitations of biophysical approaches
In the final analysis, biophysical studies
that assess the SC in a frozen state can
provide valuable information about
highly organized structures, such as
intact lamellar bilayer arrays within the
SC. As these approaches do not assess
less-organized microdomains present
within the ECM, there is potential for
sampling bias in such studies. Yet, it is
within these less-organized, highly plas-
tic (dynamic) domains that subsequent
investigators may find much of the
‘‘action’’. Although Iwai et al. (2012)
bring the field forward by presenting a
more accurate model of the molecular
organization of lamellar bilayers in the
SC, it is too early to conclude that we
understand the structural basis of the
permeability barrier completely.
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Figure 1. Diagram of stratum corneum membrane domains (modified from Schmuth et al., 2008).
Clinical Implications
Molecular organization of the extracellular lamellar bilayers of the stratum
corneum has now been refined, with implications for transcutaneous
drug delivery and barrier function.
 The extracellular matrix of the stratum corneum contains more than lipids,
and several of these nonlipid constituents are important for barrier
function.
 The stratum corneum and its extracellular matrix are dynamic, changing in
structure and function during transit to the surface of skin.
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Human Nevi: No Longer Precursors of
Melanomas?
Gao Zhang1,2 and Meenhard Herlyn1
Considerable data support the idea that oncogene-induced senescence remains a
barrier that needs to be overcome for malignant transformation of melanocytes.
Human nevi stain positive for the senescence-associated b-galactosidase marker,
suggesting that cells have lost their proliferative capacity. Most nevi harbor B-RAF
or N-RAS mutations, implying that they are growth arrested via oncogene-
induced senescence pathways. It remains intriguing how benign nevus cells can
escape oncogene-induced senescence for malignant transformation to melanoma.
The report by Tran et al. in this issue shows that current senescence markers do
not distinguish nevi from melanomas, challenging the notion that nevi are growth-
arrested via senescence.
Journal of Investigative Dermatology (2012) 132, 2133–2134. doi:10.1038/jid.2012.183
Cellular senescence is a physiological
process by which cells gradually lose its
growth potential to eventually exit cell
cycle progression. The concept dates
back to 1961, when the ‘Hayflick Limit’
was discovered in senescent fibroblasts
from culture as a result of telomere
shortening (Hayflick and Moorhead,
1961). This phenomenon is described
as replicative senescence. Decades
later, a seminal observation was made
that overexpression of an oncogene can
rapidly trigger premature senescence
in normal cells, coined ‘‘oncogene-
induced senescence’’. It turns out that
oncogene-induced senescence, similar
to apoptosis, is a fail-safe mechanism
to prevent malignant transformation of
normal cells, both in vitro and in vivo.
Therefore, bypassing or escaping
senescence is a prerequisite for malig-
nant transformation. Perhaps a human
nevus is one of the best examples to
illustrate the role of overcoming
senescence in initiating a tumor
(Michaloglou et al., 2005; Dhomen
et al., 2009). Human nevi are growth-
arrested for decades. However, facili-
tated by cooperating genetic lesions, a
few nevus cells can develop into a
malignant melanoma. For example,
oncogenic B-RAFV600E can induce
melanocyte senescence in mice and
zebrafish (Dankort et al., 2009;
Dhomen et al., 2009; Ceol et al.,
2011). Loss of p53 or the phosphatase
and tensin homolog, or overexpression
of SETDB1, can accelerate melanoma
formation, presumably by abrogating
oncogene-induced senescence (Patton
et al., 2005; Dankort et al., 2009; Ceol
et al., 2011).
Numerous markers have been reported
to identify senescent cells, including
senescence-associated (SA)-b-galactosi-
dase, promyelocytic leukemia protein,
SA heterochromatin foci (HMGA2,
HP1g, H3K9Me3, MacroH2A1.2, HIRA,
DAPI (4’,6-diamidino-2-phenylindole)
staining, DcR2, DEC1, p16INK4a, DNA
damage markers (gH2AX and p53), and
Ki-67Neg. It is worth noting that markers
should be multiplexed for the detection of
senescence to increase the confidence in
assessment.
In contrast, Tran et al. (2012, this
issue) failed to distinguish human
melanocytic nevi from metastatic
melanomas when using a panel of
senescence markers. The investigators
first carried out immunofluorescence
staining on human benign nevi and
melanomas, using p16INK4a, p53,
gH2AX, Ki-67, promyelocytic leukemia
protein, and H3K9Me3 antibodies.
Although p16INK4a and Ki-67 are good
markers, the others could not distinguish
nevi from melanomas. In a subsequent
experiment, most nevi (5/7), as well as a
subset of metastatic melanomas (3/7),
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